UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN C000000291
Receipt number R000000368
Scientific Title Study of Docetaxel followed by FEC as primary systemic chemotherapy for operable breast cancer (JBCRG-03)
Date of disclosure of the study information 2005/11/25
Last modified on 2021/08/13 16:24:34

No. Disposal Last modified on Item of update
1 Insert 2005/11/25 11:31:38
2 Update 2006/01/30 18:04:11 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
3 Update 2006/11/09 08:07:19 Recruitment status
4 Update 2006/12/27 08:42:30 Institute
Institute
5 Update 2007/06/26 11:00:37 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other related information
Other related information
6 Update 2008/06/19 16:07:39 UMIN ID1
7 Update 2008/06/23 11:03:53 Division name
Address
Address
TEL
Email
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
8 Update 2008/12/16 11:55:45 Email1
9 Update 2011/11/15 12:18:37 Recruitment status
Other related information
Other related information
10 Update 2011/11/15 14:41:50 Other related information
11 Update 2011/11/15 15:32:59 Publication of results
Other related information
Other related information
12 Update 2011/11/15 15:56:21 Other related information
Other related information
13 Update 2013/06/17 16:09:15 Acronym
Acronym
14 Update 2016/07/05 11:40:32 Email
Address
Address
TEL
Address
Address
TEL
Name of primary person or sponsor
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Address1
Tel1
Email1
15 Update 2018/08/23 17:29:15 Acronym
16 Update 2019/11/21 16:06:12 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Organization
Zip code
Address
Organization
Institute
Organization1
Organization
Organization
Address
Address
Tel
Email
17 Update 2021/08/13 16:24:35 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures